
|Articles|September 1, 2003
Health plans' top priority : boost M+C rates now
Author(s)Jill Wechsler
MCOs want flexibility while analysts challenge the ability of private plans to control costs
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers highlight DR-70 as a possible biomarker for early bladder cancer detection
2
COVID-19 vaccines could help tumors respond better to immune checkpoint inhibitors
3
FDA approves Poherdy, first biosimilar of Perjeta, to treat HER-positive breast cancer
4
Cogent Biosciences’ phase 3 PEAK trial marks an advance in the treatment of gastrointestinal stromal tumors.
5


















































